SHPPF OTC
Redcare Pharmacy N.V.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -13.6%
1Y: -56.3%
3Y: +50.2%
$64.80
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2.9B
+24.0% ▲
5Y CAGR: +24.9%
Gross Profit
$593M
+8.7% ▲
5Y CAGR: +22.0%
Operating Income
-$24M
+39.0% ▲
Net Income
-$38M
+17.1% ▲
EPS (Diluted)
$-1.87
+17.3% ▲
EBITDA
$46M
+61.9% ▲
5Y CAGR: +33.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.8B | $2.4B | $2.9B |
| YoY Growth | +9.5% | +13.6% | +49.4% | +31.8% | +24.0% |
| Cost of Revenue | $794M | $873M | $1.4B | $1.8B | $2.3B |
| Gross Profit | $267M | $332M | $440M | $546M | $593M |
| Gross Margin | 25.1% | 27.5% | 24.5% | 23.0% | 20.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $197M | $244M | $267M | $357M | $427M |
| Operating Expenses | $332M | $401M | $458M | $585M | $617M |
| Operating Income | -$66M | -$69M | -$17M | -$39M | -$24M |
| Operating Margin | -6.2% | -5.7% | -1.0% | -1.6% | -0.8% |
| Interest Expense | $9M | $9M | $8M | $8M | $20M |
| Income Before Tax | -$78M | -$84M | -$14M | -$48M | -$48M |
| Tax Expense | -$4M | -$6M | -$3M | -$1M | -$8M |
| Net Income | -$74M | -$78M | -$12M | -$45M | -$38M |
| Net Margin | -7.0% | -6.4% | -0.7% | -1.9% | -1.3% |
| EPS (Diluted) | $-4.15 | $-4.32 | $-0.63 | $-2.26 | $-1.87 |
| EBITDA | -$42M | -$36M | $51M | $28M | $46M |
| Shares Outstanding | 18M | 18M | 19M | 20M | 20M |